Skip to main content

Articles By Cassandra Calabrese, DO

vaccine_6.jpg

Herpes Zoster Vaccine Update

By Cassandra Calabrese, DO
25 November 2019

Shingrix (GSK), the herpes zoster subunit vaccine (a two-shot series), was approved by the FDA in Fall 2018 and is currently approved for use in adults 50 years and older.

Read Article
influenza-156098_640.png

Influenza Vaccine Updates And Pearls At ACR 2019

By Cassandra Calabrese, DO
20 November 2019

As we enter flu season it is of the utmost importance that we remember to assess our patients’ influenza vaccine status at each visit.

Read Article
vasculitis.Churg-Strauss_syndrome.wikipedia_1.jpg

Autoimmunity in the Setting of Primary Immunodeficiency

By Cassandra Calabrese, DO
23 October 2018

There are many avenues for interdisciplinary collaboration within rheumatology, as our specialty encompasses every organ system and diseases with protean manifestations.

Read Article
gout.toe_.MTP__0.jpg

TRIPLE Trial Results

By Cassandra Calabrese, DO
22 October 2018

Pegloticase has become an excellent option for management of patients with chronic refractory gout, although treatment may be limited by the development of anti-drug antibodies that lead to loss of serum urate (sUA) lowering effect.

Read Article
syringe_1.jpg

High Dose Flu Vaccine for Patients Younger Than 65?

By Cassandra Calabrese, DO
21 October 2018

We are diving head first into flu season and we need to prepare ourselves. Last year we now know that 80,000 Americans died from influenza.

Read Article
lyme.map_.jpg

CDC Lyme Disease Surveillance Report

By Cassandra Calabrese, DO
27 November 2017

Lyme disease, caused by the spirochete Borrelia burdofgeri, is the most common vector-borne illness reported in the U.S.

Read Article
question-mark-1872634_640.jpg

Practice Patterns of PJP Prophylaxis Among ID Physicians

By Cassandra Calabrese, DO
08 November 2017

While the incidence of pneumocystis pneumonia (PJP) is low is patients with rheumatologic diseases the mortality is quite high compared to PJP in patients with HIV and infection can be prevented with appropriate prophylaxis.

Read Article
figure-1691868_640.jpg

Comparative Risk of Biologic Therapies in RA Patients Undergoing Elective Arthroplasty

By Cassandra Calabrese, DO
07 November 2017

During today’s plenary session Micheal D. George, et al. presented results of a study that sought to compare risk of post-op infections in RA patients undergoing arthroplasty exposed to biologic DMARDs versus methotrexate.

Read Article
Screen%20Shot%202017-11-06%20at%203.33.54%20PM.png

Low-dose Bactrim Safe with Methotrexate in AAV

By Cassandra Calabrese, DO
06 November 2017

A high proportion of GPA patients receive pneumocystis prophylaxis, usually with TMP-SMX (Bactrim), and drug interactions are always a concern.  

Read Article
yes-1183407_640.jpg

Increasing Incidence of Paradoxical Autoimmune Disease with Biologics?

By Cassandra Calabrese, DO
05 November 2017

With the increasing use of biologic therapies to treat rheumatic disease has come an awareness of a small but real risk of developing de novo autoimmune disease. 

Read Article
×